Tuberculosis, Leprosy and Buruli Ulcer are diseases of public health importance in Nigeria, affecting thousands of Nigeria with high level or morbidity, disability and mortality among those affected. Nigeria has the highest burden of TB in Africa and is also among the few countries that are still notifying above 1,000 cases of Leprosy annually.

The country in 2022 recorded the highest TB notification ever since the establishment of the NTBLCP in 1989. A total of 285,561 TB cases was notified in 2022, this represents more than 100% achievement of the target set for TB case finding and notification for the year 2022 in the National strategic plan. The country recorded a high treatment success rate of 89% in 2022.

The laboratory network includes 419 (405 plus 14 installed in 2021) installed GeneXpert machines, 3398 microscopy centers and 10 TB culture/LPA laboratories. These laboratories are in the primary, secondary and tertiary level of implementation depending on the type of tests. However, the primary tools are majorly conducted at all levels of implementation. A total of 11 TB-LAMP platform was installed across 7 states (Anambra, Nasarawa, Kano, Rivers, Cross Rivers, Katsina, and Taraba) in 2021. There is additional 1 PPM facility in FCT supporting the FCT TBL with TB Lamp (Epiconsult diagnostics). There is an expected expansion of 25 TB- LAMP machines in 2022.

The 2020 annual report of the NTBLCP has been developed to highlight the progress made in accelerating TB case finding in Nigeria despite the COVID-19 pandemic, provide comprehensive report on programme performance in the efforts towards controlling TB, Leprosy and BU diseases in Nigeria. It gives detailed analysis on progress made at state and LGA level and identifies key challenges to programme implementation and priority area of focus in 2018 towards ending TB epidemic in Nigeria.